Spectrum and management of hypertriglyceridemia among children in clinical practice

Pediatrics

Volumn 123, Issue 2, 2009, Pages 458-465

  Manlhiot, Cedric ^a   Larsson, Per ^a   Gurofsky, Rebecca C ^a   Smith, Ryan W ^a   Fillingham, Catherine ^a   Clarizia, Nadia A ^a   Chahal, Nita ^a   Clarke, Joseph T ^a   McCrindle, Brian W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Dyslipidemias; Hyperlipidemias; Pediatrics; Triglycerides

Indexed keywords

BILE ACID SEQUESTRANT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; BLOOD; INFANT; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INFANT; INFANT, NEWBORN; MALE; OBESITY; RETROSPECTIVE STUDIES;

EID: 61549085317     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-0367     Document Type: Article

References (42)

1. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res. 2002;43(12): 1997-2006
2. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007;176(8):1113-1120
3. Boyd GS, Koenigsberg J, FalknerB, Gidding S, Hassink S.Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents. Pediatrics. 2005;116(2):442-446
4. Garcés C, Gutierrez-Guisado J, Benavente M, et al. Obesity in Spanish schoolchildren: relationship with lipid profile and insulin resistance. Obes Res. 2005;13(6):959-963
5. Jacobs MJ, Kleisli T, Pio JR, et al. Prevalence and control of dyslipidemia among persons with diabetes in the United States. Diabetes Res Clin Pract. 2005;70(3):263-269
6. Lai SW, Ng KC, Lin HF, Chen HL. Association between obesity and hyperlipidemia among children. Yale J Biol Med. 2001; 74(4):205-210
7. Reinehr T, Andler W, Denzer C, Siegried W, Mayer H, Wabitsch M. Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis. 2005;15(3):181-187
8. Sherry N, Hassoun A, Oberfield SE, et al. Clinical and metabolic characteristics of an obese, Dominican, pediatric population. J Pediatr Endocrinol Metab. 2005;18(11):1063-1071
9. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 1998;338(23): 1650-1656
10. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111-1115
11. Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol. 1996;16(8):984-991
12. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur Heart J. 1998; 19(suppl A):A2-A11
13. Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993; 328(17):1220-1225
14. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000;86(9):943-949
15. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population- based prospective studies. J Cardiovasc Risk. 1996;3(2):213-219
16. Hopkins PN, Wu LL, Hunt SC, Brinton EA. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol. 2005;45(7):1003-1012
17. Athyros VG, Giouleme OI, Nikolaidis NL, et al. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol. 2002;34(4):472-475
18. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990;19(4):783-791
19. Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36(1):54-62
20. McCrindle BW. Screening and management of hyperlipidemia in children. Pediatr Ann. 2000;29(8):500-508
21. Napoli C, D' Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997; 100(11):2680-2690
22. Groner JA, Joshi M, Bauer JA. Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents. Pediatrics. 2006;118(4):1683-1691
23. Reinehr T, de Sousa G, Toschke AM, Andler W. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr. 2006;84(3):490-496
24. Centers for Disease Control and Prevention. Growth Charts for the United States: Methods and Development. Hyattsville, MD: Department of Health and Human Services; 2000. Report 246
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502
26. Austin MA, McKnight B, Edwards KL, et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation. 2000;101(24):2777-2782
27. Satoh H, Nishino T, Tomita K, Tsutsui H. Fasting triglyceride is a significant risk factor for coronary rtery disease in middle-aged Japanese men. Circ J. 2006;70(3):227-231
28. Avins AL, Neuhaus JM. Do triglycerides provide meaningful information about heart disease risk? Arch Intern Med. 2000; 160(13):1937-1944
29. Crowther NJ, Ferris WF, Ojwang PJ, Rheeder P. The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women. Clin Endocrinol (Oxf). 2006;64(5):535-541
30. Hu D, Hannah J, Gray RS, et al. Effects of obesity and body fat distribution on lipids and lipoproteins innondiabetic American Indians: the Strong Heart Study. Obes Res. 2000;8(6):411-421
31. Sabin MA, Ford AL, Holly JM, Hunt LP, Crowne EC, Shield JP. Characterisation of morbidity in a UK, hospital based, obesity clinic. Arch Dis Child. 2006;91(2):126-130
32. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948 -1967
33. Jonkers IJ, Smelt AH, Princen HM, et al. Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia. J Nutr. 2006;136(4):987-991
34. Balk E, Chung M, Lichtenstein A, et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Evid Rep Technol Assess (Summ). 2004;(93):1-6
35. Kreisberg RA, Oberman A. Medical management of hyperlipidemia/ dyslipidemia. J Clin Endocrinol Metab. 2003;88(6):2445-2461
36. Wheeler KA, West RJ, Lloyd JK, Barley J. Double blind trial of bezafibrate in familial hypercholesterolaemia. Arch Dis Child. 1985;60(1):34 -37
37. Ginsberg HN. Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy. Am J Cardiol. 2001;87(10):1174 -1180
38. Isaacsohn J, Hunninghake D, Schrott H, et al. Effects of sim- vastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia. Clin Cardiol. 2003;26(1):18-24
39. McCrindle BW, Helden E, Cullen-Dean G, Conner WT. A randomized crossover trial of combinationpharmacologic therapy in children with familial hyperlipidemia. Pediatr Res. 2002; 51(6):715-721
40. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr. 1997;130(2):266-273
41. Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L. Efficacy and safety of cholestyramine therapy in peripubertal and pre- pubertal children with familial hypercholesterolemia. JPediatr. 1996;129(1):42-49
42. Tonstad S, Ose L. Colestipol tablets in adolescents with familial hypercholesterolaemia. Acta Paediatr. 1996;85(9):1080-1082